Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Piroxicam Compounded Oral is dosed at 0.3 mg/kg PO q24-48h in dogs, per Knapp DW, Richardson RC, Chan TC, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med. 1994;8(4):273-278. doi:10.1111/j.1939-1676.1994.tb03232.x — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.1062 (2026-08-01). — Plumb's 10th ed (held) printed p.1033, Piroxicam monograph spanning p.1033-1034; page located 2026-08-05 from the book's own running heads, verified to name the drug in its body text. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207. Piroxicam Compounded Oral is used in dogs for Squamous cell carcinoma (palliative), Transitional cell carcinoma (TCC/urothelial carcinoma). Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 2 cited dose rules for Piroxicam Compounded Oral in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Feldene Vet Compounded
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.3 mg/kg | q24-48h | Long-term palliative; monitor renal values and for GI bleeding | Squamous cell carcinoma (palliative) | Moderate | Knapp DW, Richardson RC, Chan TC, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med. 1994;8(4):273-278. doi:10.1111/j.1939-1676.1994.tb03232.x — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.1062 (2026-08-01). — Plumb's 10th ed (held) printed p.1033, Piroxicam monograph spanning p.1033-1034; page located 2026-08-05 from the book's own running heads, verified to name the drug in its body text. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
| PO | 0.3 mg/kg | q24-48h | Long-term palliative; GI protectants recommended concurrently | Transitional cell carcinoma (TCC/urothelial carcinoma) | Strong | Knapp DW, Richardson RC, Chan TC, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med. 1994;8(4):273-278. doi:10.1111/j.1939-1676.1994.tb03232.x — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.1062 (2026-08-01). — Plumb's 10th ed (held) printed p.1033, Piroxicam monograph spanning p.1033-1034; page located 2026-08-05 from the book's own running heads, verified to name the drug in its body text. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
Every held source for this drug and species, as printed. Where they differ, both are shown — the choice is yours, not ours.
| Dose (mg/kg) | Route | Source | As printed |
|---|---|---|---|
| 0.3 | PO | BSAVA Small Animal Formulary, 10th ed — Part A (Canine and Feline)p.345 | 0.3 mg/kg p.o. q24-72h; start at least frequent administration and slowly increase if no side effec |
| 0.3 | PO | Papich Saunders Handbook of Veterinary Drugs, 4th edp.672 | • Cancer treatment: Dogs also have tolerated 0.3 mg/kg q24h PO. |
Figures are transcribed from the cited page or table of each held edition and are shown for reference only. They are not dose recommendations, they do not feed the calculator, and none has been reviewed by a veterinarian.
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Non-selective COX inhibitor with anti-proliferative and anti-angiogenic properties used as adjunctive treatment for transitional cell carcinoma and other tumors.
GI ulceration risk significant — use with misoprostol or omeprazole. Monitor BUN/creatinine. Every-other-day dosing common to reduce toxicity. Not for cats.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Piroxicam Compounded Oral dose ranges in dogs, with cited source references: PO 0.3 mg/kg q24-48h; PO 0.3 mg/kg q24-48h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Piroxicam Compounded Oral in dogs: PO.
Cited course lengths for Piroxicam Compounded Oral in dogs include: Long-term palliative; monitor renal values and for GI bleeding; Long-term palliative; GI protectants recommended concurrently. Duration depends on the indication — match it to the specific dose rule in the table above.
Piroxicam Compounded Oral is indicated in dogs for: Squamous cell carcinoma (palliative), Transitional cell carcinoma (TCC/urothelial carcinoma).
These are general warnings for Piroxicam Compounded Oral across species; consult the dog dosing table above for species-specific guidance. GI ulceration risk significant — use with misoprostol or omeprazole. Monitor BUN/creatinine. Every-other-day dosing common to reduce toxicity. Not for cats.
Why a species-specific page? Piroxicam Compounded Oral pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.